PPM3 Cost-Effectiveness of Axicabtagene Ciloleucel (AXI-CEL) VS Standard of Care for Adult Patients with Relapsed or Refractory Diffuse Large B-CELL Lymphoma in Sweden, Norway, Finland, and Denmark
Value in Health（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要